Cancer stem cells: Potential target for bioactive food components

Journal of Nutritional Biochemistry

Volumn 23, Issue 7, 2012, Pages 691-698

  Kim, Young S ^a   Farrar, William ^b   Colburn, Nancy H ^b   Milner, John A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer stem cells; Curcumin; EGCG; Genistein; Piperine; Sulforaphane; Theanine; Vitamins A and D

Indexed keywords

1,23,25 TRIHYDROXYCOLECALCIFEROL; BMI1 PROTEIN; CHOLESTEROL; CHOLINE; CURCUMIN; CYCLIN DEPENDENT KINASE 6; DICKKOPF 1 PROTEIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; NOTCH RECEPTOR; PIPERINE; RETINOIC ACID; RETINOL; SECRETED FRIZZLED RELATED PROTEIN 2; SONIC HEDGEHOG PROTEIN; SULFORAPHANE; THEANINE; VITAMIN D; WNT PROTEIN;

ADIPOCYTE; B LYMPHOCYTE; BRAIN TUMOR; BREAST CANCER; CANCER PREVENTION; CANCER STEM CELL; CELL DIFFERENTIATION; CELL RENEWAL; CHROMOSOME STRUCTURE; DIETARY INTAKE; EPIGENETICS; GENE EXPRESSION; HUMAN; LIPID OXIDATION; LIVER STEM CELL; MESENCHYMAL STEM CELL; MOLONEY LEUKEMIA ONCOVIRUS; NEURAL STEM CELL; PANCREAS TUMOR; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TARGET CELL; WNT SIGNALING PATHWAY;

ALKALOIDS; BENZODIOXOLES; CATECHIN; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLINE; CURCUMIN; CYCLIN-DEPENDENT KINASE 6; DIET; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENISTEIN; GLUTAMATES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; PIPERIDINES; PLANT EXTRACTS; POLYUNSATURATED ALKAMIDES; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; STAT1 TRANSCRIPTION FACTOR; THIOCYANATES; VITAMIN A; VITAMIN D; WNT PROTEINS;

EID: 84862318675     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.03.002     Document Type: Review

References (98)

1. Katoh M. Networking of WNT, FGF, Notch, BMP, and hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 2007, 3:30-38.
2. Haegebarth A., Clevers H. Wnt Signaling, Lgr5, and stem cells in the intestine and skin. Am J Pathol 2009, 174:715-721.
3. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., et al. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131:1109-1123.
4. Lessard J., Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003, 423:255-260.
5. Southall T.D., Egger B., Gold K.S., Brand A.H. Regulation of self-renewal and differentiation in the drosophila nervous system. Cold Spring Harb Symp Quant Biol 2008, 73:523-528.
6. Zaret K.S., Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008, 322:1490-1494.
7. Boyer L.A., Plath K., Zeitlinger J., Brambrink T., Medeiros L.A., Lee T.I., et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006, 441:349-353.
8. Gangaraju V.K., Lin H. MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 2009, 10:116-125.
9. Barroca V., Lassalle B., Coureuil M., Louis J.P., Le Page F., Testart J., et al. Mouse differentiating spermatogonia can generate germinal stem cells in vivo. Nat Cell Biol 2009, 11:190-196.
10. McCormack M.P., Young L.F., Vasudevan S., de Graaf C.A., Codrington R., Rabbitts T.H., et al. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 2010, 327:879-883.
11. Ginestier C., Wicinski J., Cervera N., Monville F., Finetti P., Bertucci F., et al. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 2009, 8:3297-3302.
12. Balasubramanian S., Adhikary G., Eckert R.L. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis 2010, 31:496-503.
13. Desbordes S.C., Placantonakis D.G., Ciro A., Socci N.D., Lee G., Djaballah H., et al. High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell 2008, 2:602-612.
14. Li Y., Zhang T., Korkaya H., Liu S., Lee H.F., Newman B., et al. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res 2010, 16:2580-2590.
15. 3 associated to the differentiation of human colon cancer cells. Carcinogenesis 2007, 28:1877-1884.
16. 3. Oncogene 2008, 27:4467-4477.
17. Kakarala M., Brenner D.E., Korkaya H., Cheng C., Tazi K., Ginestier C., et al. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 2010, 122:777-785.
18. Carlo-Stella C., Dotti G., Mangoni L., Regazzi E., Garau D., Bonati A., et al. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein. Blood 1996, 88:3091-3100.
19. Mehedint M.G., Niculescu M.D., Craciunescu C.N., Zeisel S.H. Choline deficiency alters global histone methylation and epigenetic marking at the Re1 site of the calbindin 1 gene. FASEB J 2010, 24:184-195.
20. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006, 66:9339-9344.
21. Ayyanan A., Civenni G., Ciarloni L., Morel C., Mueller N., Lefort K., et al. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci U S A 2006, 103:3799-3804.
22. Zhao C., Blum J., Chen A., Kwon H.Y., Jung S.H., Cook J.M., et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007, 12:528-541.
23. Korkaya H., Wicha M.S. Cancer stem cells: nature versus nurture. Nat Cell Biol 2010, 12:419-421.
24. Peterlik M., Cross H.S. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 2005, 35:290-304.
25. Pálmer H.G., González-Sancho J.M., Espada J., Berciano M.T., Puig I., Baulida J., et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001, 154:369-387.
26. 3 is abrogated by Snail1 in human colon cancer cells. Endocr Relat Cancer 2007, 14:141-151.
27. Jenab M., Bueno-de-Mesquita H.B., Ferrari P., van Duijnhoven F.J., Norat T., Pischon T., et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 2010, 340:b5500.
28. Cianferotti L., Cox M., Skorija K., Demay M.B. Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc Natl Acad Sci U S A 2007, 104:9428-9433.
29. Alfaro M.P., Vincent A., Saraswati S., Thorne C.A., Hong C.C., Lee E., et al. sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. J Biol Chem 2010, 285:35645-35653.
30. Su Y., Simmen F.A., Xiao R., Simmen R.C. Expression profiling of rat mammary epithelial cells reveals candidate signaling pathways in dietary protection from mammary tumors. Physiol Genomics 2007, 30:8-16.
31. Suzuki H., Toyota M., Carraway H., Gabrielson E., Ohmura T., Fujikane T., et al. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 2008, 98:1147-1156.
32. Helferich W.G., Andrade J.E., Hoagland M.S. Phytoestrogens and breast cancer: a complex story. Inflammopharmacology 2008, 16:219-226.
33. Messina M., Wu A.H. Perspectives on the soy-breast cancer relation. Am J Clin Nutr 2009, 89:1673S-1679S.
34. Dolinoy D.C., Huang D., Jirtle R.L. Maternal nutrient SUPPL.ementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 2007, 104:13056-13061.
35. Lindvall C., Evans N.C., Zylstra C.R., Li Y., Alexander C.M., Williams B.O. The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. J Biol Chem 2006, 281:35081-35087.
36. Kim J., Zhang X., Rieger-Christ K.M., Summerhayes I.C., Wazer D.E., Paulson K.E., et al. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J Biol Chem 2006, 281:10865-10875.
37. Zeng Y.A., Nusse R. Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell 2010, 6:568-577.
38. Asano Y., Okamura S., Ogo T., Eto T., Otsuka T., Niho Y. Effect of (-)-epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemia. Life Sci 1997, 60:135-142.
39. Chen C.N., Liang C.M., Lai J.R., Tsai Y.J., Tsay J.S., Lin J.K. Capillary electrophoretic determination of theanine, caffeine, and catechins in fresh tea leaves and oolong tea and their effects on rat neurosphere adhesion and migration. J Agric Food Chem 2003, 51:7495-7503.
40. Kwak M.K., Kensler T.W. Targeting NRF2 signaling for cancer chemoprevention. Toxicol Appl Pharmacol 2010, 244:66-76.
41. Ye L., Dinkova-Kostova A.T., Wade K.L., Zhang Y., Shapiro T.A., Talalay P. Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin Chim Acta 2002, 316:43-53.
42. Hidalgo M., Maitra A. The hedgehog pathway and pancreatic cancer. N Engl J Med 2009, 361:2094-2096.
43. Takezaki T., Hide T., Takanaga H., Nakamura H., Kuratsu J.I., Kondo T. Essential role of the hedgehog signaling pathway in human glioma-initiating cells. Cancer Sci 2011, 102:1306-1312.
44. Zhao C., Chen A., Jamieson C.H., Fereshteh M., Abrahamsson A., Blum J., et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009, 458:776-779.
45. Huang X., Litingtung Y., Chiang C. Region-specific requirement for cholesterol modification of sonic hedgehog in patterning the telencephalon and spinal cord. Development 2007, 134:2095-2105.
46. Eaton S. Multiple roles for lipids in the hedgehog signalling pathway. Nat Rev Mol Cell Biol 2008, 9:437-445.
47. Steinhauer J., Treisman J.E. Lipid-modified morphogens: functions of fats. Curr Opin Genet Dev 2009, 19:308-314.
48. Dwyer J.R., Sever N., Carlson M., Nelson S.F., Beachy P.A., Parhami F. Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells. J Biol Chem 2007, 282:8959-8968.
49. 3 secretion. PLoS Biol 2006, 4:1397-1410.
50. Bijlsma M.F., Peppelenbosch M.P., Spek C.A. (Pro-)vitamin D as treatment option for hedgehog-related malignancies. Med Hypotheses 2008, 70:202-203.
51. 3 in a murine xenograft model for pancreatic cancer. Cancer Biol Ther 2010, 10:79-88.
52. Markestad T. Plasma concentrations of vitamin D metabolites in unsupplemented breast-fed infant. Eur J Pediatr 1983, 141:77-80.
53. Yauch R.L., Gould S.E., Scales S.J., Tang T., Tian H., Ahn C.P., et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008, 455:406-410.
54. Slusarz A., Shenouda N.S., Sakla M.S., Drenkhahn S.K., Narula A.S., MacDonald R.S., et al. Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res 2010, 70:3382-3390.
55. Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004, 10:6847-6854.
56. Bisht S., Mizuma M., Feldmann G., Ottenhof N.A., Hong S.M., Pramanik D., et al. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther 2010, 9:2255-2264.
57. Kelleher F.C. Hedgehog signaling and therapeutics in pancreatic cancer. Carcinogenesis 2011, 32:445-451.
58. Lim K.J., Bisht S., Bar E.E., Maitra A., Eberhart C.G. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther 2011, 11:464-473.
59. Korkaya H., Wicha M.S. HER-2, notch, and breast cancer stem cells: targeting an axis of evil. Clin Cancer Res 2009, 15:1845-1847.
60. Farnie G., Clarke R.B. Mammary stem cells and breast cancer-role of Notch signalling. Stem Cell Rev 2007, 3:169-175.
61. Harrison H., Farnie G., Howell S.J., Rock R.E., Stylianou S., Brennan K.R., et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 2010, 70:709-718.
62. Bouras T., Pal B., Vaillant F., Harburg G., Asselin-Labat M.L., Oakes S.R., et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 2008, 3:429-441.
63. Reedijk M., Odorcic S., Chang L., Zhang H., Miller N., McCready D.R., et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 2005, 65:8530-8537.
64. Miele L. Rational targeting of Notch signaling in breast cancer. Expert Rev Anticancer Ther 2008, 8:1197-1202.
65. Rizzo P., Osipo C., Pannuti A., Golde T., Osborne B., Miele L. Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer. Adv Enzyme Regul 2009, 49:134-141.
66. Tiwari V.K., McGarvey K.M., Licchesi J.D., Ohm J.E., Herman J.G., Schübeler D., et al. PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biol 2008, 6:2911-2927.
67. Simon J.A., Lange C.A. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 2008, 647:21-29.
68. Fischle W., Wang Y., Jacobs S.A., Kim Y., Allis C.D., Khorasanizadeh S. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev 2003, 17:1870-1881.
69. Grinstein E., Wernet P. Cellular signaling in normal and cancerous stem cells. Cell Signal 2007, 19:2428-2433.
70. Mohty M., Szydlo R.M., Yong A.S., Apperley J.F., Goldman J.M., Melo J.V. Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia. Blood 2008, 112:2163-2166.
71. Cui H., Hu B., Li T., Ma J., Alam G., Gunning W.T., et al. Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol 2007, 170:1370-1378.
72. Zhang C., Toulev A., Kamarashev J., Qin J.Z., Dummer R., Döbbeling U. Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the bmi-1 and ras oncogenes in disease progression. Hum Pathol 2007, 38:995-1002.
73. Henning S.M., Niu Y., Lee N.H., Thames G.D., Minutti R.R., Wang H., et al. Bioavailability and antioxidant activity of tea flavonols after consumption of green tea, black tea, or a green tea extract SUPPL.ement. Am J Clin Nutr 2004, 80:1558-1564.
74. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010, 9:775-789.
75. Shkumatava A., Stark A., Sive H., Bartel D.P. Coherent but overlapping expression of microRNAs and their targets during vertebrate development. Genes Dev 2009, 23:466-481.
76. Zimmerman A.L., Wu S. MicroRNAs, cancer and cancer stem cells. Cancer Lett 2011, 300:10-19.
77. Zhu H., Shah S., Shyh-Chang N., Shinoda G., Einhorn W.S., Viswanathan S.R., et al. Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies. Nat Genet 2010, 42:626-630.
78. Takanabe R., Ono K., Abe Y., Takaya T., Horie T., Wada H., et al. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun 2008, 376:728-732.
79. Tang X., Muniappan L., Tang G., Ozcan S. Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA 2009, 15:287-293.
80. Tryndyak V.P., Ross S.A., Beland F.A., Pogribny I.P. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol Carcinog 2009, 48:479-487.
81. Marsit C.J., Eddy K., Kelsey K.T. MicroRNA responses to cellular stress. Cancer Res 2006, 66:10843-10848.
82. Peters E.S., McClean M.D., Liu M., Eisen E.A., Mueller N., Kelsey K.T. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers Prev 2005, 14:476-482.
83. Kutay H., Bai S., Datta J., Motiwala T., Pogribny I., Frankel W., et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006, 99:671-678.
84. Nikcević G., Savić T., Kovacević-Grujicić N., Stevanović M. Up-regulation of the SOX3 gene expression by retinoic acid: characterization of the novel promoter-response element and the retinoid receptors involved. J Neurochem 2008, 107:1206-1215.
85. Giuliano C.J., Kerley-Hamilton J.S., Bee T., Freemantle S.J., Manickaratnam R., Dmitrovsky E., et al. Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta 2005, 1731:48-56.
86. Purton L.E., Bernstein I.D., Collins S.J. All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood 2000, 95:470-477.
87. Purton L.E., Dworkin S., Olsen G.H., Walkley C.R., Fabb S.A., Collins S.J., et al. RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J Exp Med 2006, 203:1283-1293.
88. Dong H., Chen X., Xiang S., Liang H., Zhang W., Jing K., et al. The epithelial-mesenchymal transition promotes trans-differentiation of subcutaneously implanted hepatic oval cells into mesenchymal tumor tissue. Stem Cells Dev 2009, 18:1293-1298.
89. Sanders L.M., Zeisel S.H. Choline: dietary requirements and role in brain development. Nutr Today 2007, 42:181-186.
90. Zeisel S.H. Choline and brain development. Present knowledge in nutrition 2006, Vol. 1:352-360. ILSI Press, Washington, DC. 9th ed. B.R. Bowman, R.M. Russell (Eds.).
91. Kroonen J., Nassen J., Boulanger Y.G., Provenzano F., Capraro V., Bours V., et al. Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection. Int J Cancer 2011, 129:574-585.
92. Mellott T.J., Kowall N.W., Lopez-Coviella I., Blusztajn J.K. Prenatal choline deficiency increases choline transporter expression in the septum and hippocampus during postnatal development and in adulthood in rats. Brain Res 2007, 1151:1-11.
93. Shaw G.M., Finnell R.H., Blom H.J., Carmichael S.L., Vollset S.E., Yang W., et al. Choline and risk of neural tube defects in a folate-fortified population. Epidemiology 2009, 20:714-719.
94. Crossno J.T., Majka S.M., Grazia T., Gill R.G., Klemm D.J. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 2006, 116:3220-3228.
95. Chatterjee T.K., Stoll L.L., Denning G.M., Harrelson A., Blomkalns A.L., Idelman G., et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 2009, 104:541-549.
96. Xu F., Yang C.C., Gomillion C., Burg K.J. Effect of ceramide on mesenchymal stem cell differentiation toward adipocytes. Appl Biochem Biotechnol 2010, 160:197-212.
97. Guan F., Handa K., Hakomori S.I. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci U S A 2009, 106:7461-7466.
98. Guan F., Schaffer L., Handa K., Hakomori S.I. Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-{beta}. FASEB J 2010, 24:4889-4903.